Copyright ©The Author(s) 2020.
World J Hepatol. Oct 27, 2020; 12(10): 693-708
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.693
Figure 1
Figure 1 Locally advanced intrahepatic cholangiocarcinoma. A and B: 48F with large, multifocal intrahepatic cholangiocarcinoma who received 5 cycles of neoadjuvant gemcitabine/cisplatin; C and D: She experienced an excellent response and underwent extended left hepatectomy with pathology showing T2N0 moderately differentiated cholangiocarcinoma with negative margins.